Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep;178(3):309-320.
doi: 10.1002/ajmg.c.31637. Epub 2018 Aug 16.

A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)

Affiliations
Review

A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)

Petrus J de Vries et al. Am J Med Genet C Semin Med Genet. 2018 Sep.

Abstract

Tuberous sclerosis complex (TSC) is associated with a wide range of behavioral, psychiatric, intellectual, academic, neuropsychological, and psychosocial difficulties, which are often underdiagnosed and undertreated. Here, we present a clinical update on TSC-associated neuropsychiatric disorders, abbreviated as "TAND," to guide screening, diagnosis, and treatment in practice. The review is aimed at clinical geneticists, genetic counselors, pediatricians, and all generalists involved in the assessment and treatment of children, adolescents and adults with TSC, and related disorders. The review starts with a summary of the construct and levels of TAND, before presenting up-to-date information about each level of investigation. The review concludes with a synopsis of current and future TAND research.

Keywords: ADHD; TANDTSC; anxiety; autism spectrum disorder; behavior; depression; mental health; neuropsychological deficits; scholastic difficulties.

PubMed Disclaimer

Similar articles

Cited by

References

    1. American Psychiatric Association. Diagnostic and Statistical Manual of Psychiatric Disorders. 5. Arlington, VA: American Psychiatric Publishing; 2013.
    1. Asato MR, Hardan AY. Neuropsychiatric problems in tuberous sclerosis complex. Journal of Child Neurology. 2004;19(4):241–249. - PubMed
    1. Bissler JJ, Kingswood JC, Radzikowska E, Zonnenberg BA, Frost M, Belousova E, … Budde K. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. The Lancet. 2013;381(9869):817–824. doi: 10.1016/S0140-6736(12)61767-X. - DOI - PubMed
    1. Bolton PF, Clifford M, Tye C, Maclean C, Humphrey A, le Marechal K, … Yates JR. Intellectual abilities in tuberous sclerosis complex: risk factors and correlates from the Tuberous Sclerosis 2000 Study. Psychological Medicine. 2015;45(11):2321–2331. doi: 10.1017/S0033291715000264. - DOI - PubMed
    1. Bolton PF, Park RJ, Higgins JNP, Griffiths PD, Pickles A. Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain. 2002;125(6):1247–1255. - PubMed

Publication types

MeSH terms